GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CORT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Corcept Therapeutics Incorporated stock price down 1.48% on Thursday
(Updated on Apr 18, 2024)

Sell candidate since Apr 17, 2024 Loss -1.48% PDF

The Corcept Therapeutics Incorporated stock price fell by -1.48% on the last day (Thursday, 18th Apr 2024) from $23.00 to $22.66. During the last trading day the stock fluctuated 3.85% from a day low at $22.57 to a day high of $23.44. The price has fallen in 6 of the last 10 days and is down by -9.54% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -15 thousand shares and in total, 943 thousand shares were bought and sold for approximately $21.36 million.

The stock has broken the wide and weak rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $23.08. A reaction back to this level may hold a second chance to get out before further falls.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CORT Signals & Forecast

There are few to no technical positive signals at the moment. The Corcept Therapeutics Incorporated stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $23.33 and $24.18. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -11.97%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Corcept Therapeutics Incorporated stock

Corcept Therapeutics Incorporated finds support from accumulated volume at $21.87 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.87 between high and low, or 3.85%. For the last week, the stock has had daily average volatility of 3.30%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CORT) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Corcept Therapeutics Incorporated to open at $22.89, and during the day (based on 14 day Average True Range), to move between $21.73 and $23.59, which gives a possible trading interval of +/-$0.93 (+/-4.13%) up or down from last closing price. If Corcept Therapeutics Incorporated takes out the full calculated possible swing range there will be an estimated 8.25% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $21.87 (3.49%) than the resistance at $23.56 (3.97%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Corcept Therapeutics Incorporated stock A Buy?

The Corcept Therapeutics Incorporated stock holds several negative signals and despite the positive trend, we believe Corcept Therapeutics Incorporated will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.810 Sell Candidate Unchanged

Predicted Opening Price for Corcept Therapeutics Incorporated of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$22.89 ( 1.02%) $22.66

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CORT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 23.76 4.85 %
R2 23.43 3.39 %
R1 23.22 2.48 %
Current price: 22.66
Support S1 22.56 -0.452 %
S2 22.35 -1.36 %
S3 22.02 -2.82 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 24.46 7.94 %
R2 24.42 7.77 %
R1 23.56 3.97 %
Current price 22.66
Support S1 21.87 -3.49%
S2 21.66 -4.41%
S3 21.63 -4.55%

FAQ

What is the symbol for Corcept Therapeutics Incorporated Stock and on which exchange is it traded?
The symbol for Corcept Therapeutics Incorporated is CORT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Corcept Therapeutics Incorporated Stock?
The Corcept Therapeutics Incorporated stock holds several negative signals and despite the positive trend, we believe Corcept Therapeutics Incorporated will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Corcept Therapeutics Incorporated Stock?
Corcept Therapeutics Incorporated Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Corcept Therapeutics Incorporated Stock.

What's the current price of Corcept Therapeutics Incorporated Stock?
As of the end of day on the 2024-04-18, the price of an Corcept Therapeutics Incorporated (CORT) share was $22.66.

What is the 52-week high and low for Corcept Therapeutics Incorporated Stock?
The 52-week high for Corcept Therapeutics Incorporated Stock is $34.28 and the 52-week low is $20.87.

What is the market capitalization of Corcept Therapeutics Incorporated Stock?
As of the 2024-04-18, the market capitalization of Corcept Therapeutics Incorporated is 2.381B.

When is the next earnings date for Corcept Therapeutics Incorporated?
The upcoming earnings date for Corcept Therapeutics Incorporated is May 01, 2024.
Click to get the best stock tips daily for free!

About Corcept Therapeutics Incorporated

Corcept Therapeuticsorporated Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ... CORT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT